From June 16 to 18, 2026, the 24th Convention on Pharmaceutical Ingredients China (CPHI China 2026) was held at the Shanghai New International Expo Center. Grand Shuyang Life Sciences (Chengdu) Co., Ltd. made its debut at Booth E3A21. In collaboration with Grand Life Sciences (Qingdao) Co., Ltd., Grand Life Sciences (Liaoning) Co., Ltd., and Grand Medical Nutrition Sciences (Wuhan) Co., Ltd., it showcased Grand Life Sciences Group's industrial layout and innovative achievements in the fields of 

On June 14, 2026, we will celebrate the 23rd World Blood Donor Day. Centered on the theme "A Drop of Passionate Blood, A Ray of Love; Voluntary Blood Donation Saves Lives," Grand Shuyang Life Sciences (Chengdu) Co., Ltd. took the lead in responding through concrete action by launching the "Corporate Mission, Shuyang's Commitment" Voluntary Blood Donation Week from June 3 to June 10.

Recently, the Sichuan Provincial Department of Economy and Information Technology officially announced the list of companies recognized as "Advanced Intelligent Factories" in Sichuan Province for 2026. As a core force in China's blood products industry, Grand Shuyang, having previously received municipal-level honors for intelligent manufacturing in Chengdu, successfully passed the rigorous provincial evaluation and was listed, owing to its systematic layout and solid achievements in digital tra

Recently, Grand Shuyang's new pre-filled syringe formulation of Human Tetanus Immunoglobulin has received the relevant marketing approvals, marking a significant step forward for the Company in upgrading the dosage forms of human immunoglobulin products, enhancing clinical convenience, and refining quality management.

On May 15–16, 2026, the 2026 Rabies Conference in China was grandly held at the Yellow River Guest House in Zhengzhou, with the theme "Joint Prevention and Control, Societal Co-governance, Fortifying Defenses, and Containing the Epidemic". The conference was co-hosted by the Chinese Preventive Medicine Association, the Chinese Association of Animal Science and Veterinary Medicine, and the China Working Dog Management Association, and organized by the Rabies Prevention and Control Committee of th

On May 12, 2026, International Nurses Day, the "Safeguarding Lives · Showcasing Skills—Grand Shuyang 2026 Nursing Skills Competition," hosted by Grand Shuyang, successfully concluded at the Anzhou Plasmapheresis Center in Mianyang. Twenty-two nursing backbones from Grand Shuyang's 18 plasmapheresis centers nationwide gathered to compete fiercely in venipuncture techniques, full-process plasma collection operations and theoretical knowledge, thoroughly testing the professional competence of the p

On April 01, a symposium on supply-demand matching for intelligent robots in biopharmaceutical enterprises, jointly organized by the Bio-industry Development Bureau and the Digital Economy Bureau of Chengdu High-Tech Industrial Development Zone, and hosted by Grand Shuyang Life Sciences (Chengdu) Co., Ltd., was successfully held at Grand Shuyang.

March 21, 2026, Beijing, China — Grand Life Sciences Group Co., Ltd. (hereinafter referred to as "Grand Life Sciences") and Belief BioMed Inc. (hereinafter referred to as "Belief BioMed") officially signed an exclusive commercialization cooperation agreement in Beijing. Under the agreement, Grand Life Sciences secured exclusive commercialization rights in the Chinese mainland, Hong Kong, Macau, and Taiwan regions of China for Belief BioMed's investigational product BBM-H803 Injection, a gene the

Recently, the Health Commission of Sichuan Province officially released the list of provincial healthy enterprises. Grand Shuyang was honored with the title of “Provincial Healthy Enterprise of Sichuan.” for its outstanding practices in the field of health management. This honor signifies that the Company's overall capabilities in corporate health promotion have been acknowledged by provincial authorities.

Recently, Grand Shuyang was officially certified as a "Healthy Enterprise" in Chengdu, marking a significant achievement in employee health management, corporate humanistic development, and sustainable development. The Company has currently initiated the application process for provincial-level Healthy Enterprise certification and continues to advance its health management to a higher standard.

December 12, 2025, Chengdu—To fully implement the "Healthy China" initiative, further promote the spirit of humanitarian dedication, and advance the standardization and sustainable development of source plasma management in the blood products industry, Grand Shuyang Life Sciences (Chengdu) Co., Ltd. (hereinafter referred to as "Grand Shuyang") held the "2025 Annual Commendation for Plasma Donors and Blood Source Development Conference".

The "2nd China Plasma Protein Industry Development Conference" was held in Chengdu, Sichuan from November 07 to 09, 2025. Themed "Plasma Protein Drugs: Enhancing Independent Innovation Capabilities and Upgrading Industrial Development Level", this conference was hosted by the China Biochemical Pharmaceutical Industry Association and organized by the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences and the Plasma Protein Branch of the Association. It brought together indu